Abstract Details

Title Evaluating the Aggregate Safety Profile of Disease Modifying Therapies Used in the Treatment of Relapsing Forms of Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 159

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Cathryn Carroll (Teva Pharmaceuticals)	No disclosure on file
	No disclosure on file
Daniel B. Snyder, PhD (Revance Therapeutics Inc.)	No disclosure on file
	No disclosure on file

��ɫ��